Published in Transplantation on November 01, 1975
Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4. Clin Exp Immunol (1981) 0.84
Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest (1971) 4.98
DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest (1973) 2.66
Bronchiectasis: update of an orphan disease. Am Rev Respir Dis (1988) 1.79
Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol (1973) 1.68
DTT test: a new method to differentiate IgM and IgG erythrocyte antibodies. Vox Sang (1974) 1.59
Immune haemolytic disease: the autoimmune haemolytic anaemias. Clin Haematol (1975) 1.56
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia. J Immunol (1974) 1.56
The diagnosis and treatment of Raynaud's phenomenon. Surgery (1975) 1.51
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
The clinical spectrum of aspergillosis--part 2: classification and description of saprophytic, allergic, and invasive variants of human disease. Crit Rev Clin Lab Sci (1981) 1.46
Shared antigens between Mycobacterium bovis (BCG) and other bacterial species. Science (1972) 1.41
The three "Rs": reform, rationing and their repercussions on the allergist/immunologist in the United States. Ann Allergy (1993) 1.38
Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol (1979) 1.36
The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE). Am J Med (1975) 1.30
The clinical significance of Raynaud's syndrome. Surgery (1976) 1.25
Pulmonary hypersensitivity to Alternaria and Aspergillus in baker's asthma. Clin Allergy (1977) 1.18
Digital ischemia and gangrene preceding renal neoplasm. An association with sarcomatoid adenocarcinoma of the kidney. Arch Intern Med (1976) 1.14
The general and specific humoral immune response to pulmonary aspergillosis. Am Rev Respir Dis (1975) 1.14
Individual patient variations in the kinetics of intravenous immune globulin administration. J Clin Immunol (1982) 1.10
Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med (1974) 1.10
The clinical spectrum of aspergillosis--part 1: epidemiology, pathogenicity, infection in animals and immunology of Aspergillus. Crit Rev Clin Lab Sci (1981) 1.05
Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science (1982) 1.04
Intravenous immune globulin therapy in hypogammaglobulinemia. A review. Am J Med (1984) 1.03
Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med (1984) 0.99
Antilymphocyte antisera in immunologically mediated renal disease. JAMA (1969) 0.99
Clinical aspects of autoimmune hemolytic anemia. Semin Hematol (1976) 0.98
Addisonian pernicious anemia with positive antiglobulin tests. A multiple autoimmune disease syndrome. Am J Clin Pathol (1968) 0.98
Allergic bronchopulmonary aspergillosis and bilateral fungal balls terminating in disseminated aspergillosis. J Allergy Clin Immunol (1980) 0.98
Antigenic Differences Between Mycobacterium bovis Strain BCG and an Isoniazid-Resistant Mutant. Infect Immun (1971) 0.97
Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions. Ann Allergy (1991) 0.95
Autoimmune hemolytic anemia and neoplasia of the reticuloendothelium. With a hypothesis concerning etiologic relationships. Ann Intern Med (1968) 0.95
Autoimmune hemolytic anemia and ulcerative colitis: a multisystem immunodeficiency disease? Int Arch Allergy Appl Immunol (1970) 0.95
Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J Med (1977) 0.91
Safety and patient acceptability of intravenous immune globulin in 10% maltose. Lancet (1980) 0.91
Cellular immunity in Guamanians with amyotrophic lateral sclerosis and Parkinsonism-dementia. N Engl J Med (1978) 0.91
Structure and biological functions of human IgD. VI. Serum IgD in patients with allergic bronchopulmonary aspergillosis. Int Arch Allergy Appl Immunol (1976) 0.90
Aspergillus antibody in patients with cystic fibrosis. Am J Dis Child (1975) 0.90
Diet-induced systemic lupus erythematosus (SLE) in primates. Am J Kidney Dis (1982) 0.87
Potential adverse health effects of wood smoke. West J Med (1989) 0.87
Seasonal variation in bronchial hyperreactivity (BHR) in allergic patients. Clin Rev Allergy Immunol (1997) 0.86
The primary interaction of antibody to components of aspergilli. II. Antibodies in sera from normal persons and from patients with aspergillosis. J Allergy Clin Immunol (1972) 0.86
Clinical and bronchial provocation studies in patients with meatwrappers' asthma. J Allergy Clin Immunol (1976) 0.85
Hereditary aspects of autoimmune hemolytic anemia; a retrospective analysis. Vox Sang (1968) 0.85
Measurement of DNA/anti-DNA complexes. Scand J Rheumatol Suppl (1975) 0.85
Occupational asthma secondary to low molecular weight agents used in the plastic and resin industries. Eur J Respir Dis (1983) 0.84
Clinical studies on the significance of DNA:anti-DNA complexes in the systemic circulation and cerebrospinal fluid (CSF) of patients with systemic lupus erythematosus. J Rheumatol (1975) 0.84
Immunosuppressive therapy for severe chronic uveitis. Arch Ophthalmol (1978) 0.84
Dietary amino acid-induced systemic lupus erythematosus. Rheum Dis Clin North Am (1991) 0.83
Immunosuppressive therapy in rheumatic disease. Med Clin North Am (1977) 0.83
Building-related illness. A review of available scientific data. Clin Rev Allergy (1988) 0.83
Thermoactivated price-label fume intolerance. A cause of meat-wrapper's asthma. JAMA (1976) 0.83
Rapid onset of hand ischemia of unknown etiology: clinical evaluation and follow-up of ten patients. Ann Surg (1977) 0.83
Antigen heterogeneity of human B and T lymphocytes. J Clin Invest (1976) 0.83
Utilization of intravenous dihydroxypropyl theophylline (dyphylline) in an aminophylline-sensitive patient, and its pharmacokinetic comparison with theophylline. J Allergy Clin Immunol (1980) 0.82
"Foreign serum" heterophile antibodies in patients receiving antithymocyte antisera. Blood (1973) 0.82
Humoral immunity in bronchiectasis. Ann Allergy (1987) 0.81
Structure and biological functions of human IgD. VII. IgD antinuclear antibodies in sera of patients with autoimmune disorders. Int Arch Allergy Appl Immunol (1976) 0.81
Heparin sensitivity. Report of a case. Arch Intern Med (1973) 0.80
The primary interaction of antibody to components of aspergilli. I. Immunologic and chemical characteristics of a nonprecipitating antigen. J Allergy Clin Immunol (1972) 0.80
Neuropsychiatric involvement in systemic lupus erythematosus. Birth Defects Orig Artic Ser (1978) 0.80
Cellular immune competence in the human fetus. Cell Immunol (1973) 0.79
Pancytopenia during ingestion of alfalfa seeds. Lancet (1981) 0.79
Head and neck manifestations of autoimmune disease. Am J Otolaryngol (1983) 0.79
Effects of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody. Am J Med (1983) 0.79
Allergic bronchopulmonary aspergillosis (ABPA): studies on the general and specific humoral response. Mycopathologia (1978) 0.78
The use of cultures and immunologic procedures to predict oropharyngeal candidiasis in patients on steroid aerosols. Clin Allergy (1982) 0.78
Asthma in the elderly: the importance of patient education. Compr Ther (1996) 0.78
Antithymocyte antisera theapy in nonsurgical immunologic disease. Transplant Proc (1971) 0.78
Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25. Vox Sang (1991) 0.78
Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communication. Vox Sang (1988) 0.77
Positive antiglobulin reactions complicating urological surgery. J Urol (1966) 0.77
Amphotericin B and cryptococcal infection. An objective method for the evaluation of treatment. Arch Intern Med (1968) 0.77
Silent renal involvement in systemic lupus erythematosus. Int Arch Allergy Appl Immunol (1977) 0.77
Measurement of humoral antibodies to aspergilli. Ann N Y Acad Sci (1974) 0.76
Myasthenia gravis treated with purified antithymocyte antiserum. Neurology (1979) 0.76
Synergistic immunosuppressive action of antithymocyte antisera and thymectomy in the human. Clin Exp Immunol (1972) 0.75
Is asthma really different in the elderly patient? J Asthma (1993) 0.75
Azathioprine in steroid-insensitive nephropathy. Am J Med (1970) 0.75
Inhibition of lymphocyte growth by Ulex seed extracts (USE). Immunology (1981) 0.75
The specialty of allergy/immunology is not overrepresented in the physician workforce. Ann Allergy Asthma Immunol (1999) 0.75
Recent advances in the immunopathogenesis of systemic lupus erythematosus. West J Med (1975) 0.75
Immunologic mechanisms in renal disease. N Engl J Med (1971) 0.75